Showing results (81-90 of 134) with videos related to
Sort By:
Pageof 14
Journal of Medicinal Chemistry|May 12, 2011
Design, synthesis, and SAR studies of 4-substituted methoxylbenzoyl-aryl-thiazoles analogues as potent and orally bioavailable anticancer agentsYan Lu, Chien-Ming Li, Zhao Wang, et al.Endocrinology|August 16, 2005
Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized ratsWenqing Gao, Peter J Reiser, Christopher C Coss, et al.The Journal of Pharmacology and Experimental Therapeutics|January 26, 2006
Preclinical pharmacology of a nonsteroidal ligand for androgen receptor-mediated imaging of prostate cancerJun Yang, Casey E Bohl, Vipin A Nair, et al.Journal of Medicinal Chemistry|February 6, 2004
Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulatorsCraig A Marhefka, Wenqing Gao, Kiwon Chung, et al.Investigative Ophthalmology & Visual Science|June 21, 2012
β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularizationAnand Giddabasappa, Jeetendra R Eswaraka, Christina M Barrett, et al.Bioorganic & Medicinal Chemistry|July 22, 2011
Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerizationJianjun Chen, Chien-Ming Li, Jin Wang, et al.International Journal of Oncology|September 3, 2010
2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathwaysChien-Ming Li, Ramesh Narayanan, Yan Lu, et al.Current Oncology Reports|May 4, 2016
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)Jeffrey Crawford, Carla M M Prado, Mary Ann Johnston, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancerVeeresa Gududuru, Eunju Hurh, Gangadhar G Durgam, et al.Pharmaceutical Research|December 10, 2003
Structural determinants of P-glycoprotein-mediated transport of glucocorticoidsCharles R Yates, Cheng Chang, Jeffrey D Kearbey, et al.Pageof 14